Ma Vmvk Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 M
- Revenue Growth 1349.28%
- Profit Growth 679.84%
- Ebitda 865.96%
- Net Worth 474.24%
- Total Assets 202.68%
About Ma Vmvk Pharma
Ma Vmvk Pharma Private Limited (MVPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2020 (Four years and four months 3 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.70 M.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100WB2020PTC240178
-
Company No.
240178
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Sep 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Ma Vmvk Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Majeji
|
Director | 20-May-2021 | Current |
|
Vandana Majeji
|
Director | 07-Dec-2022 | Current |
Financial Performance of Ma Vmvk Pharma.
Vmvk Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1349.28% increase. The company also saw a substantial improvement in profitability, with a 679.84% increase in profit. The company's net worth Soared by an impressive increase of 474.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ma Vmvk Pharma?
In 2022, Ma Vmvk Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Positive Tracon Pvt LtdVipul Majeji is a mutual person
-
Vmvk Mercantile Private Limited
Vipul Majeji and Vandana Majeji are mutual person
Charges (Loans)
₹1.70 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2023 | Hdfc Bank Limited | ₹1.70 M | Open |
How Many Employees Work at Ma Vmvk Pharma?
Ma Vmvk Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ma Vmvk Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ma Vmvk Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
